CD38 and COVID-19: Together, these data indicate that T cell activation in COVID-19 patients is similar to what has been observed in other acute infections or vaccinations (37, 39, 40) and identify patients with high, low, or essentially no T cell response on the basis of KI67+ or CD38+HLA-DR+ expression compared with control individuals.